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Question 1- The FDA Should Revise Their 1Q92 Policy Statement to Require
Labeling on Certain Genetically Altered Fruits and Vegetables.
Biotechnology, specically recombinant DNA (rDNA) or genetic engineering
technology, promises to revolutionize the US agricultural industry. rDNA tech-
nology allows scientists to isolate any gene encoding a desirable characteristic
in one organism and to transfer it to any other or2anism. I se of ~enetjc enamee
can alter both the
ring drastically
a2ronomlc and quality characteristics of food. Crops have been developed
which express resistance to herbicides., pesticides. viruses or frost. Other plants
have been engineered to produce food with higher nutritional value, such as an
increased proportion of unsaturated fatty acids.1
Genes may be transferred from one plant to another or may be transferred
across kinadoms. i.e. from animals or microbes to plants. Genes from ounders
have been inserted into tomatoes to promote frost-resistance and genes from
wax-moths have been inserted into potatoes to retard bruising.2 The rst ge-
netically altered fruit, the Calgene Flavr Savr tomato, has already reached the
marketplace.3
In order to clarify the regulation of genetically altered foods before they
were introduced to the marketplace,4 the FDA announced its policy towards
the regulation of genetically altered fruits and vegetables on May 29, 1992.~
The FDA stated that the products of genetically altered fruits and vegetables
would not be treated any dierently than food derived from plants developed by
traditional agricultural techniques such as hybridization. 6 The FDA believes
that all genetic modication techniques,
1
1including traditional hybrid breeding. have similar potentials to create unsafe
food, Since the safety hazard of foods produced by other genetic modication
techniques has proven to be low, there is no reason to suspect an increased
danger from genetic engineering. Therefore, since foods derived from new plant
varieties have not traditionally required premarket approval, such approval will
not be required for plants developed by genetic engineering, except in limited
circumstances.7 As long as the gene introduced into the plant is derived from a
known food source or is substantially the same as an existing food substance,
and is not know to be toxic or highly allergenic, the FDA believes that pre-
market approval under the food additive regulations is unnecessary.8
Consistent with this policy, the FDA determined that. in most cases, labeling
indicating that biotechnolo2y was used to develop the food is not requjred.
Labeling may be necessary. however if:1 a known allergen were transferred from
one food.substsnce to another; Th the hutrient content of the host food were
signicantly altered; 3 a protein. carbohydrate or fat not already common to
the food supply were added or t a host food were sucientix- altered such that
it was misleading to refer to it by the host name.9 The FDA believes that the
derivation of the food from a genetically engineered plant is not material and,
since plants derived from more traditional forms of breeding need not be labeled
hybrids, no special labeling is necessary for the products of genetic engineering.10
This FDA policy statement was issued a few months after the Bush admin-
istration announced an intention to ease the regulatory burdens on genetically
engineered products in order to foster the growth of the biotechnology indus-
try. Vice President Quayl&s Council on Competitiveness was instrumental in
developing the biotech policy in
2order to prevent overreaulation of the industry, due in part to overlapping
jurisdiction of the FDA. EPA and USDA.1'.12 Thus. it appears that the FDA
may have been inuenced by deregulation economics when establishing their
policy towards genetically altered fruits and vegetables. This perception has
contributed to the public outcry over the policy.
Generally, the FDA policy has prompted vehement complaints both from
environmental and consumer groups as being too lenient;13 however, by far the
most controversial component of the policy has been the decision not to require
labeling of genetically engineered foods. Over 3300 comments on the policy were
received by the FDA. Ninety percent of these comments were from consumers
concerned about the lack of labeling requirements for genetically engineered
foods.14 Consumer complaints were based on a number of concerns. Although
the FDA requires labeling of genetically altered foods if the added gene is a
known allergen, such as peanuts. consumers are concerned about the prospect
of the transfer of less common allergens.'5 Some Orthodox Jews feel that the
insertion of a pig or shellsh acne into apples renders them non-Kosher.16 Fi-
nally, some consumers feel that genetic engineering is akin to playing god and
is morally wrona. ]7 .18 These people want information about the genetic ma-
nipulation of their foods so that they can avoid altered foods. These concerns
prompted the FDA to reopen the issue in April of 1993 by requesting another
round of public comment on whether genetically engineered foods should be
labeled.19
The FDA's power to regulate labeling derives from x403 of the Food. Drug
and Cosmetics Act (FDCA). Subsection 403(a(1i provides that a food is mis-
branded if its labeling is false or misleading in any particular.20 Whether or not
a label is misleading depends on
3
3not only representations made or suggested ... but also the extent to which
the labeling ... fails to reveal facts material in light of such representations or
material with respect to consequences which may result from the use of the
article to which the labeling or advertising relates...21
This materiality provision has been used by the FDA to prescribe labeling
requirements which are not mandated in x403.22 Thus. in determining whether
to require labeling of genetically engineered foods. the FDA must examine the
materiality of such information.
The FDA could also look to x~03i~ 1 of the FDCA for guidance in labelin2
aeneticallv altered fruits and vegetables. x403(11(1) requires that a nonstan-
dardized food bear on its label its common or usual name 23 Accordin2 to 21
('FR 102.5. promulgated under x4031gb.
the common or usual name of a food ... shall accurately identify or describe
the basic nature of the food .... The name shall be uniform among all identical
01. similar products and may not be confusin2lx similar to the name of any
other food that is not reasonable encompassed within the same name...
Thus. according to the regulation. if a fruit or vegetable has been altered to
such an extent that it is no longer the same food product. the label would have
to indicate the dierence between the two products. The FDAs policy seems to
reect this fact,24 but line drawing diculties are likely to surface when trying
to determine whether a host organism has been altered to such an extent that it
may no longer be considered the same food 25 Since x401 of the FDCA prohibits
establishing standards of identity
a
for fresh or dried fruits and vegetables,26 these problems may not be elimi-
nated by the issuance of a standard of identity. The FDA should rely
4
4on x403(a) and x201(n) to establish rules for all genetically altered fruits and
vegetables rather than proceeding under x403Uu 1) and determining on a case
by case basis whether each altered crop is or is not the same as the host plant.
Under x403(a). for the FDA to mandate disclosure of the genetic alter-
ation of fruits and vegetables, it must deem the information material. Such
a determination would be a valid exercise of FDA power and not arbitrary or
capricious. The FDA has utilized the materiality provision to require additional
armative disclosures. Courts have traditionally interpreted the misbranding
provisions as being protective of the consumer and grant broad deference to the
FDA in its eld of expertise.27 Thus. the determination that the genetic engi-
neering of foodstus 15 material would doubtlessly be upheld by a court. if ever
challenged. Moreover, the FDA could nd precedent for requiring labeling of
2eneticallv en2ineered foodstus in its regulation of irradiated foods. The FDA
mandates thai irradiated food must be labeled as such. The FDA determined
that a labeling requirement was necessary even though. as in the case of genetic
engineering, it was satised that the procedure did not create a health hazard?8
Given the fact that the FDA could legally mandate labeling of genetically
engineered fruits and vegetables whether they should do so requires examining
the relevant policy issues. A number of issues inuence whether it is good policy
for the FDA to require labeling of genetically altered foods. These issues include
respect for consumer concerns and autonomy, public perception, eect on the
growth of the industry, the cost of the labeling requirement. and the uncertainty
as to the health eects of the technology.
5
5As pointed out previously, consumers are interested in whether or not their
food has been genetically altered. Some consumers fear health eects, others
have dietary restrictions due to reliRious beliefs and still others do not believe
that human beings should be tampering with life, or at least certain higher life
forms. Since it is impossible for a consumer to determine whether food has
been genetically altered unless this is disclosed to her, the consumer relies on
the food label for her information. The FDA should respect consumer auton-
omy by mandating that the information which they deem relevant be provided
by manufacturers 29 The FL)A indicated that public concerns are relevant in
establishing mandatory labelin2 requirements when it promulgated the labeling
rules for irradiated foods. In a release accompanying the nal rule on irradiated
food. the FDA noted that
whether information is material under section 201'.n of the act depends not
on the abstract worth of the information but on whether consumers view such
information as important 3C)
The FDA found mat the fact that a large number of consumers requested
iabelin2 was evidence of the signicance consumers placed on irradiation and.
therefore indicative of materiality31
Although the FDA has traditionally interpreted the term material to in-
clude only information which eects the attributes of the food itself,32 the FDA
should expand the denition to include all information which is relevant to the
consumer's decision whether or not to purchase a food product. If consumers
deem the use of technology to be relevant in their food consumption decision,
the FDA should respect this and mandate that food producers include this in-
formation. Since the FDA has taken nonsafety. subjective views into account
in setting some of its own policies)3 it
6
6would be hypocritical of the agency to then determine that certain consumer
ethical and religious concerns are irrational and, therefore not material, no mat-
ter how widespread the concerns are in the population.
Additionally, some consumer concerns do relate to the attributes of the food
products and, therefore, do not require a reanalysis of the term material. Many
consumers are concerned about allergenicity of these foods. Although the FDA
will require labeling of foods containing highly allergenic substances, many indi-
viduals have allergies to other proteins which may be transferred from one food
substance to another via genetic engineering. These consumers have a right to
know that a gene from a substance to which they are allergic has been trans-
ferred to another food. This concern has to do with the safety of the food and
would not require the FDA to alter its denition of materiality.
In determining whether genetic engineering of foods is suciently material to
require disclosure on food labels, the FDA must be wary of mandating that too
much information be disclosed on food labels. If the FDA takes the position that
any information which might be relevant to a consumer's decision to purchase
food must be on all food labels, then the
labels will contain too much information to be useful. Being faced with so
M~'4
many words, the consumer not read the label and, therefore, not receive
the most important information. Thus, the FDA must be certain to man-
date the inclusion of only highly relevant information on food labels. Genetic
engineering, however, meets this strict requirement. Many consumers have in-
dicated that such information is relevant to them. Consumer polls show that a
majority of the public has diculties with certain forms of genetic engineering.
Moreover, such information may be necessary to protect people from allergic
reactions.
7
7The FDA should respect consumer concerns for a reason other than deference to
personal autonomy. The FDA must ensure that it maintains public condence.
If the FDA continues to ignore consumer concerns, then the public will lose
faith in the agency. The public may begin to scrutinize FDA determinations
and refuse to buy an approved product for fear that it had not been adequately
regulated.34 Additionally, if the FDA ignores public concerns, the public may
lobby Congress for action. Congress may exert increased inuence in the FDA's
eld by introducing legislation or conducting Congressional hearings. Such a
reaction to the FDA's refusal to label genetically altered foods and drugs is
already occurring. Congress has commissioned the Oce of Technolo~' Assess-
ment to run a study on consumer perception of genetically altered crops and has
held hearings on the subject. The hearings and the OTA report disclosed public
dissatisfaction with FDA was regulation of the biotech food industry .~ A bill re-
quiring labeling of genetically altered foods has been introduced in Congress.36
To avoid additional political pressure, the FDA should pay increased attention
to public concern in this area.
A second factor in the determination of whether to mandate labeling of
genetically altered crops is the cost to industry. Although the FDA's mandate
is to protect public health, the agency should and does take the economic costs
into account when regulating. Ignoring economic consideration would result in
food market which is extremely safe and yet too expensive for most consumers.
The agricultural biotechnology industry has objected to labeling of geneti-
cally altered foods for a number of reasons. Primarily, the industry is concerned
with the irrational fears of the public. The industry believes that consumers
will not purchase bio-engineered products for fear that the
8
8products will harm their health, even though there is little or no scientic ev-
idence for this premise. Thus, the argument goes, the edgling biotechnology
industry will be destroyed if consumers are informed that what they are consum-
ing is a product of genetic engineering. This argument is not sucient to justify
denying consumers information which they deem material to their consumption
decisions. If the biotech industry is concerned that consumers have irrational
fears and do not adequately understand the safety and benets provided by
biotechnology, it is up to the industry to educate the public.37 The provision of
adequate information should be sucient to allay any consumer fears. 3S When
the food industry complained about consumer fears of irradiation, the FDA de-
termined that this was inadequate to prevent labeling of irradiated foods and
stated that the way to address this was for the industry to
a
educate the public.39
A related industry concern is that consumers will perceive any labeling of
genetic alteration as a safety warning and, therefore, will be deterred from pur-
chasing the food for unreasonable fears of health dangers.40 This concern again
underestimates consumers. Since the FDA mandates that many things be in-
cluded on labels including ingredients, weight, food name and nutritional con-
tent, consumers know that many label disclosures do not indicate safety prob-
lems. Moreover, the fact that the FDA has mandated Warnings in situations
of health concerns such as saccharin and alcohol, should indicate to consumers
that not all labeling constitutes a health warning. As with the concern over
irrational consumer fears, any misunderstanding caused by the labeling can be
addressed by increased consumer education. When the food industry raised this
concern to avoid labeling irradiated food products, the FDA
9
9found the argument unpersuasive and stated that any problem could be solved
by increasing public information.41
The agricultural biotechnology industry has also complained that required
labeling would be administratively dicult and inecient. The industry argues
that. although it would not be dicult to label genetically altered fruits and
vegetables which are sold fresh or as whole frozen or canned foods, it would
be extremely burdensome to require labeling of processed foods made from ge-
netically altered crops.42 Labeling would be particularly dicult for the bread.
grain and cereal industry be cause grain distributors generally combine grains
from various sources and sell this stock to producers. Mandatory labeling would
require isolating genetically engineered grains from un-altered grains. The ad-
ministrative requirements imposed by labeling might be so high that they would
outweigh any eciency gains from biotechnology and. thus, eectively preclude
the genetic engineering of the grain supply. Here industry raises a valid com-
plaint. However, in requiring labeling, the FDA need not require that all pro-
cessed products be labeled. The FDA could mandate that only whole foods
which are genetically altered need be labeled and allow processed foods made
from genetically altered ingredients to escape the labeling provisions. This route
was taken by the FDA for irradiated foods ~ Alternatively, the FDA could man-
date that processed foods which are made from both genetically altered and
non-altered crops indicate this on their label. This action would be similar to
the treatment of oils or dough conditioners, where the FDA allows an ingredient
list to state that the food includes one of more of the following.44
A nal concern is the uncertainty of the safety of genetically altered fruits
and vegetables. As discussed earlier, the transfer of genes from one
10
10orzanism to another brings the prospect of transferred allergenicity as well. Al-
though the FDA is mandating disclosure of known allergens. the people who
suer from less common allergies will not be protected. Additionally. although
genetic engineering has not been proven dangerous, neither has it been proven
safe. Some scientists have questioned whether the antibiotic resistant markers
necessary to determine gene uptake in the genetic engineering process might
confer resistance to human pathogens.45 Moreover. although the FDA has been
claiming that genetic engineering is little dierent from traditional genetics. it
is qualitatively dierent in the sense that it allows the transfer of genes from
very distantly related species and even between kingdoms. The eect of this on
toxicity and allergenicity is unknown and the fact that one gene often controls
more than one phenot~pic characteristic, a characteristic known as pleiotrophy.
bolsters the fear that unknown dangers may result.46 In the face of this uncer-
tainty, consumers should be provided with information so that they may make
their own cost/benet analyses as to whether the increased quality or decreased
price of the genetically altered food is worth a slight. but unknown. health
risk.47
In addition to weighing all the nolicv issues, the FDA must consider what
alternatives to mandatory labeling exist and what is likely to occur if the FDA
decides not to require labeling. One suggested alternative is that the indus-
try develop a niche market for foods which have not been genetically altered.
This would be similar to the organic foods market.48 The producers partici-
pating in the niche market would reverse label their foods as not containing
bio-engineered products.49 Niche marketing has the advantage of providing in-
formation to consumers and allowing them to determine whether to purchase
these non-manipulated foods.
11
11However, this alternative poses certain problems. One diculty is how is the
FDA to police these assertions? Should the FDA assert jurisdiction or should
the industry be left on its own? Moreover, foods sold in a niche market are likely
to be signicantly higher in price than the general food supply ,50 Finally, the
niche market alternative does not address the needs or desires of people who are
not adverse to biotechnology in general but, either for religious, moral or allergy
reasons, cannot purchase certain genetically manipulated foods. Thus, it does
not appear that the niche market is an adequate replacement for mandatory
labeling of genetically engineered foods.
If the FDA does not mandate labeling of genetically altered fruits and veg-
etables, state and local governments may do so. States like North Carolina.
Hawaii and Minnesota have already enacted laws which regulate biotech food
products more stringently than the Federal government.51 Moreover, a bill was
introduced in New York City which would mandate labelina of bio-en2ineered
food products.52 State and local regulation in this area creates tremendous prob-
lems in a national food distribution system. If food producers must comply with
diering labeling requlrements in dierent localities, it max be all but impossible
for bioengineered foods to be marketed on a nationwide level. This would have
a signicantly more harmful eect on the industry than reasonable regulation
by the FDA.
Weighing all of these factors. it appears that the FDA should mandate
disclosure of genetic alteration on food labels. The public concern over the issue,
along with possible health concerns, like allergenicity, render the information
material, making mandatory labeling a prudent policy for the FDA. It is not
necessary. however, for the FDA to require labeling of all
12
12genetically altered food substances. The best course would be to require labeling
only for those foods which have been engineered with gene products from a
species outside of the host's genus. This would be the least restrictive way
of adequately protecting the public. Since many genetically engineered crops
contain genes from close relatives or, like the Calgene tomato, are made by the
elimination or downregulation of one of the host's gene products, a signicant
fraction of genetically altered foods need not be labeled.
As the FDA has indicated, traditional crop manipulation has not had
adverse eects on the safety of fruits and vegetables. Since traditional
w
crop manipulation is nerformed on plants one genus. this proposed
regulation takes into account the proven safety of these techniques by not
requiring labeling of intra-genus genetic manipulation. However, since 1nter-
genus genetic manipulation diers signicantly from traditional aaricultural
techniques. this policy would recognize the uncertain safety of the new tech-
nique and mandate disclosure so that consumers could make their cost/benet
analysis.
Moreover, the proposed policy would adequately protect consumers who
suer from allergies. People with allergies to one food are normally on notice not
to eat closely related foods and, therefore, do not require information on whether
a gene from a wild species of plant has been inserted into an inbred species.
However, consumers will be informed when inter-genera gene manipulation has
occurred and, therefore, may steer away from foods containing genes derived
from a substance to which they are allergic.. Similarly, this regulation addresses
concerns of vegetarians and people who have dietary restrictions due to religious
reasons by disclosing the transfer of animal genes into plants.
13
13Finally, this policy takes into account the predominant view of the public to-
wards genetic engineering.53 Most people do not object to genetic manipulation
within the plant kingdom, but a majority of the public does object to the in-
sertion of animal genes into plants. Therefore, this policy provides information
that the public deems relevant. Although a certain sector of the population
believes that all genetic manipulation is immoral, the FDA cannot protect all
consumers, but must try to protect only the vast majority. ~ Moreover, those
consumers who are morally opposed to all
a
genetic manipulation should be adequately served by a niche market. La-
beling of processed foods containing genetically altered fruits and
vegetables should be required because the major concerns of allergenicity,
dietary restriction and moral concerns are no less relevant in processed foods
than in unprocessed foods. However, processed food producers should be able
to indicate that the product may contain genetically manipulated foods so that
inecient practices, such as the segregation of biotech and non-biotech foods is
unnecessary.
The FDA should consider including a sunset provision, so that this policy
may be reviewed in. say, 10 years. If after a number of such inter-genus geneti-
cally engineered crops have been marketed, no safety problems have arisen and
the public has accepted the technology, then the genetic manipulation of the
product may no longer be material and mandatory labeling could, perhaps, be
eliminated.55
One nal consideration is what to require on the label. Since listing the
added gene or protein in the ingredients would be inconsistent with FDA's
decision not to treat newly introduced genes and gene products as food additives,
such a policy is not prudent. The FDA should require that the food indicate
that it is genetically engineered somewhere on the label,
14
14allowing the producer to add the purpose of the engineering, such as genetically
engineered to preserve freshness. This policy was followed by the FDA in the
irradiation regulation56 and is prudent because it allows the producer to promote
genetic engineering by indicating its benets.
organism from which the introduced gene was derived should be indicated
on the label to protect allergic consumers.
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